Prof Jarushka Naidoo

Prof. Jarushka Naidoo, MB BCH MHS is a Professor of Medical Oncology and Consultant Medical Oncologist at the Beaumont RCSI Cancer Centre in Dublin, Ireland and Adjunct faculty at Johns Hopkins University. She specialises in lung cancer, immunotherapy and immunotherapy-related toxicity.

She has authored >100 peer-reviewed publications, and serves on the ASCO, ESMO and SITC guidelines for lung cancer, and immunotherapy toxicity. She is the recipient of several research grants including an IASLC Young Investigator Award, NIH K Award, Irish Cancer Society (ICS) Clinician Research Leader Award, and is the PI of the Beaumont-RCSI-ICS Lung Cancer Programme Grant.

She is the current Chair of the Lung Cancer Disease-specific subgroup (DSSG) of Cancer Trials Ireland and is an active clinical trialist through the ETOP and EORTC cooperative groups. She serves on the scientific committees of ASCO, ESMO, and IASLC, and is the incoming chair of the IASLC World Lung Cancer Conference 2025.